Suivre
George R Thompson
George R Thompson
Professor of Medicine, Division of Infectious Diseases, University of California - Davis
Adresse e-mail validée de ucdavis.edu
Titre
Citée par
Citée par
Année
Remdesivir for the treatment of Covid-19
JH Beigel, KM Tomashek, LE Dodd, AK Mehta, BS Zingman, AC Kalil, ...
New England Journal of Medicine 383 (19), 1813-1826, 2020
59652020
Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America
TF Patterson, GR Thompson III, DW Denning, JA Fishman, S Hadley, ...
Clinical infectious diseases 63 (4), e1-e60, 2016
28052016
Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group …
JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ...
Clinical Infectious Diseases 71 (6), 1367-1376, 2020
19002020
Baricitinib plus remdesivir for hospitalized adults with Covid-19
AC Kalil, TF Patterson, AK Mehta, KM Tomashek, CR Wolfe, V Ghazaryan, ...
New England Journal of Medicine 384 (9), 795-807, 2021
17702021
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled …
JA Maertens, II Raad, KA Marr, TF Patterson, DP Kontoyiannis, ...
The Lancet 387 (10020), 760-769, 2016
8772016
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
FM Marty, L Ostrosky-Zeichner, OA Cornely, KM Mullane, JR Perfect, ...
The Lancet infectious diseases 16 (7), 828-837, 2016
6682016
Coccidioidomycosis: epidemiology
J Brown, K Benedict, BJ Park, GR Thompson III
Clinical epidemiology, 185-197, 2013
3082013
Oropharyngeal candidiasis in the era of antiretroviral therapy
GR Thompson III, PK Patel, WR Kirkpatrick, SD Westbrook, D Berg, ...
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2010
2422010
The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin
M Hoenigl, R Sprute, M Egger, A Arastehfar, OA Cornely, R Krause, ...
Drugs 81, 1703-1729, 2021
2262021
Synergistic reactivation of latent HIV expression by ingenol-3-angelate, PEP005, targeted NF-kB signaling in combination with JQ1 induced p-TEFb activation
G Jiang, EA Mendes, P Kaiser, DP Wong, Y Tang, I Cai, A Fenton, ...
PLoS pathogens 11 (7), e1005066, 2015
2042015
Overview of antifungal agents
GR Thompson, J Cadena, TF Patterson
Clinics in chest medicine 30 (2), 203-215, 2009
1972009
Development of Caspofungin Resistance following Prolonged Therapy for Invasive Candidiasis Secondary to Candida glabrata Infection
GR Thompson III, NP Wiederhold, AC Vallor, NC Villareal, JS Lewis, ...
Antimicrobial agents and chemotherapy 52 (10), 3783-3785, 2008
1942008
Isavuconazole treatment of cryptococcosis and dimorphic mycoses
GR Thompson, A Rendon, R Ribeiro dos Santos, F Queiroz-Telles, ...
Reviews of Infectious Diseases 63 (3), 356-362, 2016
1872016
Valley Fever: Finding New Places for an Old Disease: Coccidioides immitis Found in Washington State Soil Associated With Recent Human Infection
AP Litvintseva, N Marsden-Haug, S Hurst, H Hill, L Gade, EM Driebe, ...
Clinical Infectious Diseases 60 (1), e1-e3, 2015
1802015
Coccidioidomycosis
NW Stockamp, GR Thompson
Infectious Disease Clinics 30 (1), 229-246, 2016
1742016
Aspiring antifungals: review of current antifungal pipeline developments
TJ Gintjee, MA Donnelley, GR Thompson III
Journal of Fungi 6 (1), 28, 2020
1732020
Invasive aspergillosis: current strategies for diagnosis and management
J Cadena, GR Thompson, TF Patterson
Infectious Disease Clinics 30 (1), 125-142, 2016
1632016
Fungal disease of the nose and paranasal sinuses
GR Thompson III, TF Patterson
Journal of allergy and clinical immunology 129 (2), 321-326, 2012
1602012
Isavuconazole: a comprehensive review of spectrum of activity of a new triazole
GR Thompson, NP Wiederhold
Mycopathologia 170, 291-313, 2010
1582010
Aspergillosis: epidemiology, diagnosis, and treatment
J Cadena, GR Thompson, TF Patterson
Infectious Disease Clinics 35 (2), 415-434, 2021
1512021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20